The expression of p16INK4A has been investigated in oral leukoplakias (OLK), but no data are available about oral lichen planus (OLP). In this study, p16INK4A immunohistochemical expression was evaluated in 56 OLP and 36 OLK (12 without inflammation [NI-OLK] and 24 with chronic inflammation [I-OLK]) and compared with 23 reactive nonspecific inflammations (INF) and 14 normal control samples. The p16INK4A immunostaining was considered to be positive when 5% of keratinocytes were stained. All normal control samples were negative. Positive p16INK4A was detected in OLP, IOLK, and INF. Significant differences in p16INK4A positivity were found between OLP (64%) and OLK (28%) (2 17.7; P .01), and between I-OLK and NI-OLK (2 4.5; P .05). No significant difference was found between OLP and INF (43%). In conclusion, positive p16INK4A in OLP patients seems to be related to reactive inflammatory processes rather than to a risk of progression to oral squamous cell carcinoma.
Montebugnoli L, Venturi M, Gissi DB, Leonardi E, Farnedi A, Foschini MP. (2011). Immunohistochemical expression of p16(INK4A) in oral lichen planus. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 112, 222-227 [10.1016/j.tripleo.2011.02.029].
Immunohistochemical expression of p16(INK4A) in oral lichen planus.
MONTEBUGNOLI, LUCIO;GISSI, DAVIDE BARTOLOMEO;FARNEDI, ANNA;FOSCHINI, MARIA PIA
2011
Abstract
The expression of p16INK4A has been investigated in oral leukoplakias (OLK), but no data are available about oral lichen planus (OLP). In this study, p16INK4A immunohistochemical expression was evaluated in 56 OLP and 36 OLK (12 without inflammation [NI-OLK] and 24 with chronic inflammation [I-OLK]) and compared with 23 reactive nonspecific inflammations (INF) and 14 normal control samples. The p16INK4A immunostaining was considered to be positive when 5% of keratinocytes were stained. All normal control samples were negative. Positive p16INK4A was detected in OLP, IOLK, and INF. Significant differences in p16INK4A positivity were found between OLP (64%) and OLK (28%) (2 17.7; P .01), and between I-OLK and NI-OLK (2 4.5; P .05). No significant difference was found between OLP and INF (43%). In conclusion, positive p16INK4A in OLP patients seems to be related to reactive inflammatory processes rather than to a risk of progression to oral squamous cell carcinoma.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
